Ceesay Abraham Insider Trading Activity (RAPP)

Profile

Abraham Ceesay is a corporate executive known for his roles as Director and Chief Executive Officer at Rapport Therapeutics, Inc. He has been involved in the biopharmaceutical industry, particularly focusing on the development of treatments for central nervous system disorders.

Role	Insider
Notability	20/100

Board memberships

Rapport Therapeutics, Inc.
Charles River Laboratories International, Inc.
Pacira BioSciences, Inc.

Awards & honors

Leadership in biopharmaceutical development
Focus on central nervous system disorders
Director roles in multiple companies

Recent Transactions

Date	Ticker	Company	Code	Shares	Price	Value
2026-07-15	RAPP	Rapport Therapeutics, Inc.	S — Open-market sale [10b5-1]	2.7K	$40.57	$111K
2026-07-15	RAPP	Rapport Therapeutics, Inc.	S — Open-market sale [10b5-1]	5.5K	$39.72	$218K
2026-07-01	RAPP	Rapport Therapeutics, Inc.	S — Open-market sale	876	$40.34	$35K
2026-07-01	RAPP	Rapport Therapeutics, Inc.	S — Open-market sale	7.3K	$39.77	$292K
2026-05-11	CRL	CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	A — Grant or award	1.4K	$177.62	$255K
2026-02-20	RAPP	Rapport Therapeutics, Inc.	S — Open-market sale [10b5-1]	2.1K	$29.80	$63K
2026-02-20	RAPP	Rapport Therapeutics, Inc.	S — Open-market sale [10b5-1]	3.0K	$29.04	$87K
2026-02-20	RAPP	Rapport Therapeutics, Inc.	S — Open-market sale [10b5-1]	2.3K	$29.80	$68K
2026-02-20	RAPP	Rapport Therapeutics, Inc.	S — Open-market sale [10b5-1]	3.6K	$29.05	$103K
2026-01-23	RAPP	Rapport Therapeutics, Inc.	S — Open-market sale [10b5-1]	5.1K	$26.11	$133K
2026-01-23	RAPP	Rapport Therapeutics, Inc.	S — Open-market sale [10b5-1]	5.8K	$26.12	$152K
2025-12-18	RAPP	Rapport Therapeutics, Inc.	S — Open-market sale [10b5-1]	515	$31.04	$16K
2025-12-18	RAPP	Rapport Therapeutics, Inc.	S — Open-market sale [10b5-1]	2.4K	$30.04	$73K
2025-12-18	RAPP	Rapport Therapeutics, Inc.	S — Open-market sale [10b5-1]	2.1K	$28.84	$62K
2025-12-18	RAPP	Rapport Therapeutics, Inc.	S — Open-market sale [10b5-1]	600	$31.04	$19K
2025-12-18	RAPP	Rapport Therapeutics, Inc.	S — Open-market sale [10b5-1]	2.8K	$30.04	$84K
2025-12-18	RAPP	Rapport Therapeutics, Inc.	S — Open-market sale [10b5-1]	2.4K	$28.84	$70K
2025-11-18	RAPP	Rapport Therapeutics, Inc.	S — Open-market sale	2.8K	$25.44	$72K
2025-11-18	RAPP	Rapport Therapeutics, Inc.	S — Open-market sale	2.2K	$24.91	$56K
2025-11-18	RAPP	Rapport Therapeutics, Inc.	S — Open-market sale	3.1K	$25.43	$78K

Frequently Asked Questions

Who is Ceesay Abraham?

How many SEC Form 4 filings has Ceesay Abraham submitted recently?

3 primary Form 4 filings in the last 90 days, covering 2 companies.

Has Ceesay Abraham been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 29 open-market sales ($4.22M) across all tracked filings.

Where can I see all of Ceesay Abraham's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Ceesay Abraham — SEC Form 4 Insider Trading Activity

Summary